Top News
Cellestia enters clinical development for its lead compound CB-103, a new mode of action anticancer drug targeting NOTCH positive cancers, with receiving full approval of its first-in-human Phase I – IIa clinical study.
SBA Member, 17.08.2017
Clinerion announces a new technology for patient identification using fully anonymized electronic patient data.
SBA Member, 17.08.2017
H1 2017: Tecan with significant increase in order entry and strong sales growth in the Life Sciences Business
GlobeNewswire, 16.08.2017
Clariant AG: HuntsmanClariant Deal Continues to Move Forward: Narrow "Second Request" for Additional Information Received from Federal Trade Commission
GlobeNewswire, 15.08.2017
ObsEva Reports Second Quarter 2017 Financial Results and Provides Business Update
GlobeNewswire, 15.08.2017
Tel Aviv University announces COLLABORATION with Biosynth on pioneering chemiluminescent reporter molecules
SBA Member, 15.08.2017
Basilea reports improved financial results in half-year 2017 driven by growing product sales; significant progress on partnering and development programs
SBA Member, 10.08.2017
Next Events
...
Partners
